Metlife Inc: Form 10-Q for the period ended Jun 30, 2024
Filed with the SEC on Aug 1, 2024 and accepted by EDGAR at Aug 1, 2024, 16:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-04-01 to 2024-06-30 | $558.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2024-01-01 to 2024-06-30 | $1.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Income tax | 3 months2024-04-01 to 2024-06-30 | $249.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-01-01 to 2024-06-30 | $419.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-04-01 to 2024-06-30 | $946.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-01-01 to 2024-06-30 | $1.81bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-04-01 to 2024-06-30 | $1.28 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-01-01 to 2024-06-30 | $2.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-04-01 to 2024-06-30 | $1.28 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-01-01 to 2024-06-30 | $2.39 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-04-01 to 2024-06-30 | 714,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-01-01 to 2024-06-30 | 721,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-01-01 to 2024-06-30 | $5.82bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2024-01-01 to 2024-06-30 | $766.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2024-01-01 to 2024-06-30 | $2.03bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-06-30 | $20.79bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2024-06-30 | $675.75bn | us-gaap:Assets |
| Total liabilities | At period end2024-06-30 | $648.21bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2024-06-30 | $390.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-06-30 | $27.25bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001099219-24-000201. Last ingested by Listed: Nov 6, 2026, 10:59 ET. Listed shows no prices and gives no investment advice.